Elliott Bennett-Guerrero is a professor of anesthesiology currently serving Duke University in Durham, North Carolina. Additionally, Elliott Bennett-Guerrero acts as director of perioperative clinical research at the Duke Clinical Research Institute, where he leads extensive research projects examining issues regarding blood transfusion during coronary artery bypass surgery.
Patients diagnosed with severe coronary heart disease may be recommended for a type of open heart surgery known as coronary artery bypass graft, or CABG, surgery. During the procedure, the surgeon grafts a healthy artery from another location within the body, usually the chest or leg, and binds it to the blocked coronary artery, so as to bypass the blocked portion of it. This rerouting allows blood to flow freely to the heart. CABG surgery may be performed on more than one blocked coronary artery at a time. CABG is effective in reducing angina and strengthening the pumping action of a weakened heart. Although repeat surgery may be necessary over time for some patients, the majority report a reduction or elimination of symptoms and a significantly improved quality of life.
0 Comments
Board-certified anesthesiologist Elliott Bennett-Guerrero serves Duke University as professor of anesthesiology, a position he has held since 2008. During his ongoing tenure as director of perioperative clinical research with the Duke Clinical Research Institute, in 2010 Elliott-Bennett Guerrero facilitated clinical trials on the application of gentamicin-collagen sponges onto surgical sites, the results of which were published in the New England Journal of Medicine.
There is interest in potentially using topical antibiotics to reduce the risk of surgical wound infection. Topical or local use implies that the antibiotic is administered at the site of the wound and not systemically as through an intravenous (IV) catheter or through the mouth, ie gastrointestinal tract. A potential benefit of topical antibiotics is to maintain low levels of drug in the bloodstream despite the high concentration of antibiotic around the site of application. This is important since high levels of some antibiotics in the bloodstream can be harmful, for example to the kidneys. Currently there are no FDA-approved, topically-applied antibiotics for the prevention of surgical site infection after abdominal surgery. |
AuthorDr. Elliott Bennett-Guerrero is both an educator and a vice chairman at Stony Brook Medicine. Archives
June 2022
Categories
All
|